PFBT
NVCR icon

Parkside Financial Bank & Trust’s NovoCure NVCR Stock Holding History

Parkside Financial Bank & Trust’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$491 Sell
45
-49
-52% -$612 ﹤0.01% 2572
2025
Q4 		$1.22K Sell
94
-104
-53% -$1.33K ﹤0.01% 2274
2025
Q3 		$2.56K Sell
198
-85
-30% -$1.14K ﹤0.01% 1935
2025
Q2 		$5.04K Buy
283
+20
+8% +$349 ﹤0.01% 1702
2025
Q1 		$4.69K Buy
263
+30
+13% +$681 ﹤0.01% 1651
2024
Q4 		$6.94K Hold
233
– – ﹤0.01% 1385
2024
Q3 		$3.64K Sell
233
-49
-17% -$888 ﹤0.01% 1492
2024
Q2 		$4.83K Buy
282
+84
+42% +$1.48K ﹤0.01% 1380
2024
Q1 		$3.1K Sell
198
-17
-8% -$250 ﹤0.01% 1439
2023
Q4 		$3.21K Buy
215
+145
+207% +$1.94K ﹤0.01% 1408
2023
Q3 		$1.13K Buy
70
+62
+775% +$1.79K ﹤0.01% 1810
2023
Q2 		$332 Sell
8
-36
-82% -$2.23K ﹤0.01% 1929
2023
Q1 		$2.65K Sell
44
-2
-4% -$160 ﹤0.01% 1612
2022
Q4 		$3.37K Hold
46
– – ﹤0.01% 1486
2022
Q3 		$3K Sell
46
-4
-8% -$312 ﹤0.01% 1433
2022
Q2 		$3K Buy
50
+12
+32% +$904 ﹤0.01% 1462
2022
Q1 		$3K Buy
38
+5
+15% +$368 ﹤0.01% 1506
2021
Q4 		$2K Buy
33
+24
+267% +$2.41K ﹤0.01% 1633
2021
Q3 		$1K Sell
9
-34
-79% -$5.14K ﹤0.01% 1689
2021
Q2 		$10K Buy
43
+35
+438% +$6.81K ﹤0.01% 971
2021
Q1 		$2K Hold
8
– – ﹤0.01% 1508
2020
Q4 		$2K Buy
8
+4
+100% +$547 ﹤0.01% 1432
2020
Q3 		$0 Buy
+4
New +$320 ﹤0.01% 1612

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Parkside Financial Bank & Trust's NVCR Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its NovoCure (NVCR) stake by 52% in Q1 2026, selling an estimated $612 and leaving 45 shares worth $491. The position accounts for ﹤0.01% of the portfolio, ranked #2572.

Parkside Financial Bank & Trust first reported a position in NVCR in Q3 2020 and has held it in 23 quarters since. The position peaked at $10K in Q2 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Parkside Financial Bank & Trust held 45 shares of NovoCure worth $491 as of Q1 2026.
  • Parkside Financial Bank & Trust sold 49 NovoCure shares in Q1 2026, an estimated $612.
  • NovoCure made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2572 holding.
  • Parkside Financial Bank & Trust first reported a position in NovoCure in Q3 2020 and has held it in 23 quarters since.
  • Parkside Financial Bank & Trust's NovoCure position peaked at $10K in Q2 2021.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.